|

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

RECRUITINGPhase 4Sponsored by Mayo Clinic
Actively Recruiting
PhasePhase 4
SponsorMayo Clinic
Started2019-06-27
Est. completion2030-05
Eligibility
Age60 Years+
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT03821857

Summary

The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

Eligibility

Age: 60 Years+Sex: FEMALEHealthy volunteers accepted
Mayo Clinic Rochester-

Inclusion Criteria:

* Women who previously participated in this study
* Currently aged 60 years and older
* More than six months post chemotherapy or major surgery requiring general anesthesia
* Willing and able to sign informed consent

Exclusion Criteria:

* Not able to read and speak English
* In hospice
* Claustrophobic
* If undergoing Tau imaging, cannot have QT Prolongation

Mayo Clinic Jacksonville-

Inclusion Criteria:

* African American Women
* Currently aged 60 years and older
* More than six months post chemotherapy or major surgery requiring general anesthesia
* Willing and able to sign informed consent

Exclusion Criteria:

* Not able to read and speak English
* In hospice
* Claustrophobic
* If undergoing Tau imaging, cannot have QT Prolongation

Conditions2

Alzheimer DiseaseAlzheimer's Disease

Locations2 sites

Florida

1 site
Mayo Clinic
Jacksonville, Florida, 32224
Twilla Morrell, CRC904-953-3420morrell.twila@mayo.edu

Minnesota

1 site
Mayo Clinic
Rochester, Minnesota, 55905

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.